Managing Director Of Biocon

Rediff.com » News » Managing Director Of Biocon

News for Managing Director Of Biocon

News
Business

Biz tycoons LN Mittal, Kiran Mazumdar Shaw among electoral bond buyers

Corporate donations worth thousands of crores to political parties through now-scrapped electoral bonds may have hit the headlines, but there were also 132 such bonds of just Rs 1,000 each bought......

Multi-agency group to probe Indian names in 'Pandora Papers'

The government will investigate every Indian name appearing in an unprecedented leak of financial records, known as the 'Pandora Papers', which alleged that many world leaders have secret offshore......

Noted economist Dr Isher Judge Ahluwalia passes away

Eminent economist Isher Judge Ahluwalia, a recipient of India's third-highest civilian award Padma Bhushan, passed away on Saturday. She was 74. IMAGE: Isher Judge Ahluwalia had stepped down as......

'COVID-19 will be a year-long struggle'

'Predictions are that numbers will continue to rise till May end and maybe in the first half of June will be our peak.' IMAGE: Medical workers arrive for COVID-19 testing at a containment zone in......

Plasma therapy isn't proven treatment for COVID-19: Govt

The plasma therapy for treatment of coronavirus patients is at an experimental stage and it has the potential to cause life-threatening complications, the Union health ministry said on Tuesday,......

'The formulations business been a growth driver'

'Fundamentally, we think that in the coming quarters, API business should come back.' Photograph: Kind courtesy Biocon Biocon is preparing to make the most of the peptides opportunity as these......

'APIs are a very strategic part of Biocon's business'

'There is no reason why we should break this business up.' Photograph: Kind courtesy Biocon Bengaluru-headquartered biotech major Biocon has been working to reduce its cumulative debt of around......

'Aim to be among top three biosimilar players in world'

'We've got a huge track record and success in bringing several biosimilars to the market.' IMAGE: Biocon Biologics, Biocon Park, Bengaluru. Photograph: Kind courtesy Biocon Biologics/Facebook......

Are Markets In An Oversold Zone?

'Focus on 19,400/64,900 as the key resistance levels for the Nifty/Sensex.' Illustration: Uttam Ghosh/Rediff.com Rising bond yields, driven by hawkish central bank policies and flaring......

At $171 billion in 2022, India Inc clinches highest ever yearly M&As

Aided by the $57.8-billion merger of HDFC Bank and HDFC, India Inc reported its highest ever mergers and acquisitions in calendar 2022 at $171 billion as against deals worth $145 billion announced......

Rediff News

Managing Director Of Biocon

News for Managing Director Of Biocon

Biz tycoons LN Mittal, Kiran Mazumdar Shaw among electoral bond buyers

Multi-agency group to probe Indian names in 'Pandora Papers'

Noted economist Dr Isher Judge Ahluwalia passes away

'COVID-19 will be a year-long struggle'

Plasma therapy isn't proven treatment for COVID-19: Govt

'The formulations business been a growth driver'

'APIs are a very strategic part of Biocon's business'

'Aim to be among top three biosimilar players in world'

Are Markets In An Oversold Zone?

At $171 billion in 2022, India Inc clinches highest ever yearly M&As

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS